Trial intelligence / Profile preview

STEM-AMI: G-CSF in Acute Myocardial Infarction

NCT01969890Phase 3Terminated

Sponsor
Heart Care Foundation of India
Start
Oct 2013
Primary completion
May 2018
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of filgrastim in acute anterior myocardial infarction, left ventricular systolic dysfunction (LVSD), sponsored by Heart Care Foundation of India. Started Oct 2013; status: terminated.

02

Drugs

filgrastim
03

Conditions

acute anterior myocardial infarctionleft ventricular systolic dysfunction (LVSD)

Beyond the preview

Go deeper on NCT01969890.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01969890.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call